Kaleido Biosciences Stock (NASDAQ:KLDO)


Today's Range
$4.60 - $4.84
52-Week Range
$4.10 - $16.93
Market Cap

About Kaleido Biosciences (NASDAQ:KLDO)

(NASDAQ:KLDO) Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company offers product candidates for the treatment of urea cycle disorders; hepatic encephalopathy; infections caused by multi-drug resistant bacteria; cardiometabolic and liver diseases; and immune oncology. It has a collaboration agreement with Gustave Roussy Cancer Center to develop microbiome metabolic therapies in immuno-oncology; a research collaboration with Washington University School of Medicine to explore the influence of microbiome metabolic therapies on microbial and host physiology and metabolism; and a research collaboration with Janssen to prevent childhood-onset of atopic, immune, and metabolic conditions. The company was founded in 2015 and is headquartered in Lexington, Massachusetts.
Show more

KLDO Stock Price

Statistics Highlights (NASDAQ:KLDO)

Shares Outstanding 42.59M Beta -0.34
Public Float 19.36M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 4.71% Ex-Dividend Date
Held by Institutions 81.96% IPO Date Feb 28, 2019

KLDO Financial Summary

Dec 20 Dec 19 Dec 18
Revenue $975.00K $0.00 $0.00
EBITDA $-77.00M $-85.34M $-59.03M
Net Income $-81.62M $-86.33M $-61.74M
Total Assets $59.34M $82.31M $85.33M
Total Cash $46.22M $71.24M $76.09M
Total Debt $21.01M $20.46M $14.92M
Sep 21 Jun 21 Mar 21
Revenue $104.00K $211.00K $297.00K
EBITDA $-21.78M $-22.60M $-21.76M
Net Income $-23.09M $-23.89M $-23.04M
Total Assets $67.80M $84.29M $105.03M
Total Cash $55.66M $71.98M $92.36M
Total Debt $21.52M $21.34M $21.19M

KLDO Stock Price History

Kaleido Biosciences Annual Stock Price History

Year Open Close Change
2022 $2.61 $4.69 79.69%
2021 $9.55 $2.61 -72.67%
2020 $5.15 $9.55 85.44%

Kaleido Biosciences Daily Stock Price History

Date Open High Low Close Change Volume
Jan 21, 2022 $2.25 $2.35 $2.12 $2.16 -4.00% 149.60K

(NASDAQ:KLDO) Stock Price FAQs

What is today's stock price of Kaleido Biosciences (NASDAQ:KLDO)?

  • The current stock price of Kaleido Biosciences (NASDAQ:KLDO) is $4.69.
  • Today KLDO stock price opened at $4.75 after previous close of $4.70.
  • During the day, Kaleido Biosciences stock quote has varied from a low of $4.60 to a high of $4.85.

What is Kaleido Biosciences's 52-week change?

  • KLDO 52-week high stock quote is $16.93, which is 261.00% above the current share price.
  • The Kaleido Biosciences (NASDAQ:KLDO) 52-week low stock price is $4.10, which is 12.60% below the current share price.
  • Kaleido Biosciences share price volatility (52-week beta) is -0.34.

Is Kaleido Biosciences a buy?

  • According to 7 analysts, the current consensus recommendation for Kaleido Biosciences stock is "Buy" at an average rating score of 3.86 (out of 5).
  • There are currently 2 "Strong Buy", 3 "Buy", 1 "Hold", 1 "Sell", and 0 "Strong Sell" analysts recommendations for the KLDO stock.
  • The 12 month average price target forecast for KLDO stock is $15.57, representing a 232.00% increase from the current KLDO stock price of $4.69.

Kaleido Biosciences (NASDAQ:KLDO) FAQ

How Much is Kaleido biosciences Worth?

Kaleido biosciences's worth today based on market capitalisation is $199.77M

How much dividend does Kaleido biosciences Pay?

The current annualized dividend payout for KLDO stock is $0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Kaleido biosciences's "Dividend" Section

When is the next earnings date for Kaleido biosciences (NASDAQ:KLDO)?

Kaleido biosciences is expected to report earnings on May 02 ,2022.
View More Details on Kaleido biosciences's 'Earnings' Section

What is Kaleido biosciences’s Price to Earning (PE) ratio?

KLDO stock also has a Price to Sales (P/S) ratio of 233.65.

What is the Kaleido biosciences's ticker?

Kaleido biosciences trades on the NASDAQ stock market in USA under the ticker symbol "KLDO". Kaleido biosciences’s stock symbol can also be displayed as "NASDAQ:KLDO".

When did KLDO go public?

Kaleido biosciences completed its initial public offering (IPO) on February 28 ,2019.

Who are the owners of Kaleido biosciences?

Kaleido biosciences (NASDAQ:KLDO) is owned by 81.95% institutional shareholders and by 4.71% insiders. The rest is owned by the public.
The 3 top institutional shareholders are "Flagship Ventures Management, Inc.", "FMR Inc" and "Harbourvest Partners, LLC", representing 65.26% of Kaleido biosciences’s total shares outstanding.
Explore More Details on Kaleido biosciences's “Ownership” Section

Who are the key executives of Kaleido biosciences (KLDO)?

Kaleido biosciences's key executive team includes the following managers:

  • Mr. Daniel L. Menichella B.A., M.B.A., Pres, CEO & Director (1959)
  • Dr. Geoffrey von Maltzahn Ph.D., Co-Founder & Director (1981)
  • Mr. William E. Duke Jr., Chief Financial Officer (1972)
  • Mr. Jerald Korn J.D., COO, Gen. Counsel & Corp. Sec. (1979)
  • Ms. Kimberly Hocknell, Sr. VP of Technical Operations (NA)
  • Dr. Johan Van Hylckama Vlieg Ph.D., Chief Scientific Officer (1969)
  • Ms. Susan Stewart J.D., Chief Regulatory Affairs ? Advisor (1961)
  • Dr. Mark A. Wingertzahn Ph.D., Sr. VP of R&D and Head of Devel. (1971)

What is Kaleido biosciences’s Sector & Industry Classification?

Kaleido biosciences (NASDAQ:KLDO) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Kaleido biosciences?

Currently the number of employees working for Kaleido biosciences is 82.

Where are Kaleido biosciences's Headquarters?

Kaleido biosciences (NASDAQ:KLDO) is headquartered in MA, United States.

What are Kaleido biosciences's Address and Phone Number?

Kaleido biosciences’s mailing address is 65 Hayden Avenue, Lexington, MA, United States, 02421.
The company’s phone number is 617 674 9000.

What is the official website for Kaleido biosciences?

Kaleido biosciences’s official website is http://www.kaleido.com